Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome

UPDATE: FIG Partners Initiates Coverage on 1st United Bancorp on Strong Balance Sheet Growth, Attractive Florida-Based Franchise


In a report published Monday, FIG Partners analyst John Rodis initiated coverage on 1st United Bancorp (NASDAQ: FUBC) with an Outperform rating and $8.50 price target.

In the report, FIG Partners noted, “We are initiating coverage of 1st United Bancorp with an ‘Outperform' rating. Our 12-month price target is $8.50/share representing potential upside of ~ 17%. On a YTD basis, FUBC shares have increased ~ 16% vs. the peer group median increase of ~ 21%. Our earnings estimates for 2013, 2014 and 2015 are $0.23, $0.37 and $0.48/share, respectively. Our 3Q13 operating estimate is $0.06 vs. the consensus estimate of $0.04/share. FUBC has shown relatively strong balance sheet growth over the last few years primarily driven by strategic acquisitions. Since 2005, the Company has completed seven bank acquisitions in Florida including three FDIC-assisted transactions. As a result, the Company has now built an attractive Florida-based franchise with ~ 26 branches throughout the South and Central part of the state.”

1st United Bancorp closed on Friday at $7.27.

Latest Ratings for FUBC

May 2014DowngradesOutperformMarket Perform
Apr 2014MaintainsMarket Perform
Sep 2013Initiates Coverage onOutperform

View More Analyst Ratings for FUBC
View the Latest Analyst Ratings

Posted-In: FIG Partners John RodisAnalyst Color Initiation Analyst Ratings


Related Articles (FUBC)

View Comments and Join the Discussion!

Latest Ratings

FRPTInitiates Coverage On60.0
NOMDInitiates Coverage On26.0
SMPLInitiates Coverage On27.0
TWNKInitiates Coverage On16.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Top Performing Industries For September 30, 2013

UPDATE: BMO Capital Markets Downgrades Ariad Pharmaceuticals on AP26113 Disappointment, Tempered ICLUSIG Expectations